Trials / Unknown
UnknownNCT02295137
Image Fusion of Preprocedural CTA With Real Time Fluoroscopy to Enhance EVAR Repair
Image Fusion of Pre-procedural CTA With Real-time Fluoroscopy to Guide Proper Renal and Visceral Arteries Catheterization During Advanced Endovascular Aortic Aneurysms Repair: A Feasibility Study
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Abdominal Aortic Aneurysm (AAA) is a potentially life threatening condition. If the aneurysm ruptures, the mortality can be as high as 80%. Endovascular aneurysms repair (EVAR) is a minimal invasive procedure and has been widely used on treating AAA. Advanced endovascular techniques are used to treat patients with more complex pathology by using custom-made devices and additional stents. In order to accomplish the technical success on advanced EVAR, with the current imaging equipment and technique for EVAR procedures (i.e. live x-ray fluoroscopy and 2-D digital subtraction angiography (DSA)), multiple angiograms on the target arteries (arteriograms) are required. Subsequently patients are exposed to higher dose of contrast and radiation, compared to conventional EVAR. This study is to assess the feasibility of proper visceral and renal arteries catheterization using a 3D model obtained from pre-procedural computed tomographic angiography (CTA), fused with real-time fluoroscopy, without contrast injection or angiographic run-offs thus minimizing the contrast use and patient radiation exposure while achieving procedure success during Advanced EVAR.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Using pre-procedural CTA to guide advanced EVAR procedure |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2014-11-20
- Last updated
- 2014-11-20
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02295137. Inclusion in this directory is not an endorsement.